Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 02:04 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)
NCT01599494 · Organon and Co · PHASE3 · withdrawn · last registry update 2022-02-03 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, Organon and Co |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against FSHR within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2022-11-30Also stopped (withdrawn): Assiut University, Letrozole + Menotropins (NCT04193930)
- 2022-08-11Also stopped (terminated): IVI Madrid, Corifollitropin alfa (NCT02402192)
- 2022-06-23Also stopped (terminated): University of British Columbia, a drug against FSHR (NCT02106689)
- 2022-04-29Results posted on the registry: University of California, San Francisco, Low dose hCG plus FSH co-trigger + Standard dose of hCG (NCT02310919)
- 2022-04-07Results posted on the registry: University of Colorado, Denver, Degarelix (GnRH antagonist) + recombinant FSH (NCT02478775)
- 2022-03-04Phase 3 first posted: Bharat Serums and Vaccines Limited, Recombinant Human Follicle Stimulating Hormone 900 IU (66.0 μg) / 1.5mL Solution for Injection in Prefilled Pen (NCT05266924)
- 2022-03-02Phase 3 first posted: Ferring Pharmaceuticals, REKOVELLE (Follitropin Delta) (NCT05263388)
- 2022-02-17Results posted on the registry: El Shatby University Hospital for Obstetrics and Gynecology, Duphaston + Gonadotropin (NCT04537078)
- 2021-12-08Phase 3 first posted: Qilu Pharmaceutical Co., Ltd., QL1012 + Gonal-f ® (NCT05149924)
- 2021-08-23Results posted on the registry: University of Miami, Natesto (NCT03203681)
- 2021-06-22Phase 3 first posted: Peking University Third Hospital, Prescription of traditional Chinese Medicine named Er Zhi Wan combined with Si Wu Tang + Recombinant Human Follitropin Alfa for Injection、Fructose Injection、Tetyacycline Hydrochloride Capsules、Cetrorelix Acetate Powder for Injection (NCT04935073)
- 2021-06-01Results posted on the registry: Ferring Pharmaceuticals, Follitropin alfa + Follitropin delta (NCT03296527)
- 2021-05-03Phase 3 first posted: Saudi German Hospital - Madinah, Controlled ovarian stimulation by Combined Clomiphene Citrate and Ubiquinol Versus hMG (NCT04870502)
- 2021-04-13Phase 3 first posted: Peking University Third Hospital, Er Zhi Wan combined with Si Wu Tang + Recombinant Human Follitropin Alfa 、Fructose 、Tetyacycline Hydrochloride Capsules、Cetrorelix Acetate Powder (NCT04842825)
- 2021-04-08Results posted on the registry: Organon and Co, Corifollitropin alfa + hCG (NCT03019575)
- 2021-03-24Results posted on the registry: Ferring Pharmaceuticals, Follitropin delta + Follitropin beta (NCT03228680)
- 2021-02-26Phase 3 first posted: Ferring Pharmaceuticals, Follitropin Delta (FE 999049) + Follitropin Alfa (GONAL-F) (NCT04773353)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision